Baxter notified customers on Jan. 22 that allocations for two sodium chloride IV solutions have been increased to 100%.

A follow-up to Baxter’s communication on December 13, 2024 regarding increases in allocations for several U.S. IV products, ...

Baxter International has increased allocations for two U.S. IV solutions to 100% following the disruption caused by Hurricane Helene at its North Cove, N.C., facility, according to a letter to ...

IV treatment is one of the most traditionalist and wide-spread treatments provided to the 90% of hospitalised patients, yet, recent supply challenges like the Baxter IV fluids crisis have shown ...

Medical Consumables Market Rapid Growth at 12.05% CAGR Propelled by Rising Chronic Diseases, Infection Control Standards, and Technological ...

Health systems will work to expand their supply chains and ink nontraditional partnerships in 2025, while trimming excessive ...

The Czech Health Ministry said supply problems were caused by market panic after a major US producer's factory stopped ...

Baxter International Inc. (BAX), headquartered in Deerfield, Illinois, is a healthcare leader committed to transforming lives ...

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.

Since 2016, the FDA has received 25 reports of unapproved epinephrine nasal solution being confused with approved epinephrine injection.

The Sterile Injectable Contract manufacturing market is expected to grow from an estimated USD 16.54 bn in 2024 to USD 34.77 bn in 2033, at a CAGR of 8.50%.